Literature DB >> 5125669

RNA-mediated transfer of tumor immunity--a new model for the immunotherapy of cancer.

P J Deckers, Y H Pilch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5125669     DOI： 10.1002/1097-0142(1971)28:5<1219::aid-cncr2820280520>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

Review 1.  Transfer factor and other T cell products.

Authors:  K Y Tsang; H H Fudenberg
Journal:  Springer Semin Immunopathol       Date:  1986

2.  'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.

Authors:  T Han
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  Immunotherapy of human malignancies with immune RNA.

Authors:  J B DeKernion; K P Ramming; Y H Pilch
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

4.  In vitro transfer of tumour-specific immunity with human 'immune' RNA.

Authors:  T Han; H Takita; P C Marabella; A Mittelman
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

5.  Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.

Authors:  T Han; J L Pauly; A Mittelman
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

Review 6.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15

7.  Transfer of experimental allergic orchitis with immune RNA studies in vivo.

Authors:  L Fainboim; M B Sztein; S Serrate; R E Mancini
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.